TB remains the leading cause of death among people living with HIV. Uganda is a high TB-burden country, and HIV accelerates ...
New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...
Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy ...
Please provide your email address to receive an email when new articles are posted on . Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates ...
Faculty investigators from UB’s Center for Integrated Global Biomedical Sciences (CIGBS) recently traveled to Zimbabwe and South Africa to address two public health challenges devastating that part of ...
News-Medical.Net on MSN
Immune dysfunction persists after combined TB and HIV therapy
The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...
Tuberculosis (TB) remains the leading cause of death among people living with HIV. Although HIV-1 and Mycobacterium tuberculosis (Mtb) coinfection remains a major public health concern, this problem ...
Nov. 29, 2023 –The COVID-19 pandemic hampered progress in fighting tuberculosis infections worldwide. Diverted funds meant that one of the world’s leading infectious killers caused 1.3 million deaths ...
Double dosing of dolutegravir and bictegravir HIV regimens in combination with rifampicin-based therapies for tuberculosis (TB) in people living with HIV showed similarly low levels of moderate to ...
Community health worker Marc Ilboudo uses a mobile application during a consultation with a child in Pousghin, Burkina Faso. The heads of state and government from nearly 200 countries gathering this ...
A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), according to new research. A therapy showing promise to help control tuberculosis ...
Hosted on MSN
HIV, TB research sites are in trouble
A TOTAL of 39 TB and HIV clinical research sites in the country are under threat due to potential funding cuts by the US, placing at least 27 HIV trials and 20 TB trials at risk. This is according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results